Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Firebrick Pharma Limited ( (AU:FRE) ) is now available.
Firebrick Pharma Limited has successfully secured $1.4 million through a new placement of shares, addressing a previous shortfall from a June fundraising effort. This capital will support the expansion of Nasodine Nasal Spray sales in the US, its distribution in Singapore, and the launch of new Nasodine-brand products in various markets by FY2026, enhancing the company’s market positioning and growth potential.
More about Firebrick Pharma Limited
Firebrick Pharma is a pharmaceutical innovator focused on developing and commercializing novel formulations and uses of povidone-iodine (PVP-I). The company has developed Nasodine Nasal Spray and is expanding its market presence in the United States, Singapore, and Fiji, with plans to launch in the Philippines.
Average Trading Volume: 93,735
Technical Sentiment Signal: Buy
Learn more about FRE stock on TipRanks’ Stock Analysis page.